Karl Hemming focuses on designing and synthesizing nitrogen‑ and sulfur‑containing heterocycles using cycloadditions and ring‑transformation strategies, creating small‑molecule scaffolds for enzyme targets and inflammation pathways in pharmaceutical discovery.